Clinical Outcomes and Healthcare Costs Associated with Laparoscopic Appendectomy in a Middle-Income Country with Universal Health Coverage. 2019

Giancarlo Buitrago, and Edgar Junca, and Javier Eslava-Schmalbach, and Ruben Caycedo, and Pilar Pinillos, and Luis Carlos Leal
Departamento de Cirugía, Facultad de Medicina, Universidad Nacional de Colombia, Carrera 45 N° 26-85, Edificio 471, Bogotá, Colombia. gbuitragog@unal.edu.co.

Although many studies have compared outcomes of laparoscopic appendectomy (LA) and open appendectomy (OA), some clinical and economic outcomes continue to be controversial, particularly in low-medium-income countries. We aimed at determining clinical and economic outcomes associated with LA versus OA in adult patients in Colombia. Retrospective, cohort study based on administrative healthcare records included all patients who underwent LA or OA in Colombia's contributory regime between July 1, 2013, and September 30, 2015. Outcomes were 30-day mortality rates, ICU admissions rates, length of stay (LOS), and hospital costs provided until discharge. Propensity score matching techniques were used to balance the baseline characteristics of patients (age, sex, comorbidities based on the Charlson index, insurer, and geographic location) and to estimate the average treatment effect (ATE) of LA as compared to OA over outcomes. A total of 65,625 subjects were included, 92.9% underwent OA and 7.1% LA. For the entire population, 30-day mortality was 0.74 per 100 appendectomies (95% CI 0.67-0.81), the mean and median LOS were 3.83 days and 1 day, respectively, and the ICU admissions rate during the first 30 days was 7.92% (95% CI 7.71-8.12). The ATE shows an absolute difference in the mortality rate after 30 days of -0.35 per 100 appendectomies (p = 0.023), in favor of LA. No effects on ICU admissions or LOS were identified. LA was found to increase costs by 514.13 USD on average, with total costs of 772.78 USD for OA and 1286.91 USD for LA (p < 0.001). In Colombia's contributory regime, LA is associated with lower 30-day mortality rate and higher hospital costs as compared to OA. No differences are found in ICU admissions or LOS.

UI MeSH Term Description Entries
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010535 Laparoscopy A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy. Celioscopy,Laparoscopic Surgical Procedures,Peritoneoscopy,Surgical Procedures, Laparoscopic,Laparoscopic Assisted Surgery,Laparoscopic Surgery,Laparoscopic Surgical Procedure,Procedure, Laparoscopic Surgical,Procedures, Laparoscopic Surgical,Surgery, Laparoscopic,Surgical Procedure, Laparoscopic,Celioscopies,Laparoscopic Assisted Surgeries,Laparoscopic Surgeries,Laparoscopies,Peritoneoscopies,Surgeries, Laparoscopic,Surgeries, Laparoscopic Assisted,Surgery, Laparoscopic Assisted
D003105 Colombia A country in northern South America, bordering the Caribbean Sea, between Panama and Venezuela, and bordering the north Pacific Ocean, between Ecuador and Panama. The capital is Bogota.
D003422 Critical Care Health care provided to a critically ill patient during a medical emergency or crisis. Intensive Care,Intensive Care, Surgical,Surgical Intensive Care,Care, Critical,Care, Intensive,Care, Surgical Intensive
D003906 Developing Countries Countries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures. LMICs,Less-Developed Countries,Low Income Countries,Low and Middle Income Countries,Lower-Middle-Income Country,Middle Income Countries,Third-World Countries,Under-Developed Countries,Developing Nations,Least Developed Countries,Less-Developed Nations,Third-World Nations,Under-Developed Nations,Countries, Middle Income,Countries, Third-World,Country, Least Developed,Country, Less-Developed,Country, Low Income,Country, Lower-Middle-Income,Country, Middle Income,Country, Third-World,Country, Under-Developed,Developed Country, Least,Developing Country,Developing Nation,Least Developed Country,Less Developed Countries,Less Developed Nations,Less-Developed Country,Less-Developed Nation,Low Income Country,Lower Middle Income Country,Lower-Middle-Income Countries,Middle Income Country,Nation, Less-Developed,Nation, Third-World,Nation, Under-Developed,Third World Countries,Third World Nations,Third-World Country,Third-World Nation,Under Developed Countries,Under Developed Nations,Under-Developed Country,Under-Developed Nation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Giancarlo Buitrago, and Edgar Junca, and Javier Eslava-Schmalbach, and Ruben Caycedo, and Pilar Pinillos, and Luis Carlos Leal
January 2020, International journal of nephrology,
Giancarlo Buitrago, and Edgar Junca, and Javier Eslava-Schmalbach, and Ruben Caycedo, and Pilar Pinillos, and Luis Carlos Leal
April 2022, Globalization and health,
Giancarlo Buitrago, and Edgar Junca, and Javier Eslava-Schmalbach, and Ruben Caycedo, and Pilar Pinillos, and Luis Carlos Leal
June 2023, Asian Pacific journal of cancer prevention : APJCP,
Giancarlo Buitrago, and Edgar Junca, and Javier Eslava-Schmalbach, and Ruben Caycedo, and Pilar Pinillos, and Luis Carlos Leal
November 2019, BMJ (Clinical research ed.),
Giancarlo Buitrago, and Edgar Junca, and Javier Eslava-Schmalbach, and Ruben Caycedo, and Pilar Pinillos, and Luis Carlos Leal
June 2024, World journal of surgery,
Giancarlo Buitrago, and Edgar Junca, and Javier Eslava-Schmalbach, and Ruben Caycedo, and Pilar Pinillos, and Luis Carlos Leal
May 2024, Value in health regional issues,
Giancarlo Buitrago, and Edgar Junca, and Javier Eslava-Schmalbach, and Ruben Caycedo, and Pilar Pinillos, and Luis Carlos Leal
December 2011, Expert review of pharmacoeconomics & outcomes research,
Giancarlo Buitrago, and Edgar Junca, and Javier Eslava-Schmalbach, and Ruben Caycedo, and Pilar Pinillos, and Luis Carlos Leal
October 2013, Health economics, policy, and law,
Giancarlo Buitrago, and Edgar Junca, and Javier Eslava-Schmalbach, and Ruben Caycedo, and Pilar Pinillos, and Luis Carlos Leal
November 2018, The Lancet. Global health,
Giancarlo Buitrago, and Edgar Junca, and Javier Eslava-Schmalbach, and Ruben Caycedo, and Pilar Pinillos, and Luis Carlos Leal
July 2020, Health research policy and systems,
Copied contents to your clipboard!